Global and China Self-administered Drugs Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Self-administered Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Eli Lilly and Company

    • Abbott Laboratories

    • Antares Pharma

    • Bristol-Myers Squibb

    • Gilead Sciences

    • Novartis AG

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Injectable Drugs

    • Inhaled Drugs

    • Transdermal Drugs

    Application:

    • Cardiovascular Diseases

    • Diabetes

    • Osteoporosis

    • Pain Management

    • Hormone Replacement

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Self-administered Drugs Industry Overview

      • 1.1.1 Self-administered Drugs Market Scope and Market Segments

      • 1.1.2 Self-administered Drugs Industry Characteristics

      • 1.1.3 Global and China Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Self-administered Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Self-administered Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Injectable Drugs

      • 1.2.2 Inhaled Drugs

      • 1.2.3 Transdermal Drugs

    • 1.3 Global Self-administered Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Cardiovascular Diseases

      • 1.3.2 Diabetes

      • 1.3.3 Osteoporosis

      • 1.3.4 Pain Management

      • 1.3.5 Hormone Replacement

      • 1.3.6 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Self-administered Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Self-administered Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Self-administered Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Self-administered Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Self-administered Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Self-administered Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Self-administered Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Self-administered Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Self-administered Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Self-administered Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Self-administered Drugs Industry PEST Analysis

    • 2.3 Self-administered Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Self-administered Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Self-administered Drugs Industry

    Chapter 3 Global and China Self-administered Drugs Market, by Manufacturer

    • 3.1 Global and China Self-administered Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Self-administered Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Self-administered Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Self-administered Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Self-administered Drugs Market Top 3 Players

    Chapter 4 Global and China Self-administered Drugs Market, by Type (2017-2028)

    • 4.1 Self-administered Drugs Market Trend, by Type

    • 4.2 Global Self-administered Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Self-administered Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Self-administered Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Self-administered Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Self-administered Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Self-administered Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Self-administered Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Self-administered Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Self-administered Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Self-administered Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Self-administered Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Self-administered Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Self-administered Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Self-administered Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Self-administered Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Self-administered Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Self-administered Drugs Market Analysis

    • 7.1 North America Self-administered Drugs Market, by Type

    • 7.2 North America Self-administered Drugs Market, by Application

    • 7.3 North America Self-administered Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Self-administered Drugs Market Analysis

    • 8.1 Europe Self-administered Drugs Market, by Type

    • 8.2 Europe Self-administered Drugs Market, by Application

    • 8.3 Europe Self-administered Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Self-administered Drugs Market Analysis

    • 9.1 APAC Self-administered Drugs Market, by Type

    • 9.2 APAC Self-administered Drugs Market, by Application

    • 9.3 APAC Self-administered Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Self-administered Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Self-administered Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Self-administered Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Self-administered Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Self-administered Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Self-administered Drugs Company Profiles

      • 11.1 Eli Lilly and Company

        • 11.1.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Eli Lilly and Company Self-administered Drugs Product Profiles, Application and Specification

        • 11.1.3 Eli Lilly and Company Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Abbott Laboratories

        • 11.2.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Abbott Laboratories Self-administered Drugs Product Profiles, Application and Specification

        • 11.2.3 Abbott Laboratories Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Antares Pharma

        • 11.3.1 Antares Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Antares Pharma Self-administered Drugs Product Profiles, Application and Specification

        • 11.3.3 Antares Pharma Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Bristol-Myers Squibb

        • 11.4.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Bristol-Myers Squibb Self-administered Drugs Product Profiles, Application and Specification

        • 11.4.3 Bristol-Myers Squibb Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Gilead Sciences

        • 11.5.1 Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Gilead Sciences Self-administered Drugs Product Profiles, Application and Specification

        • 11.5.3 Gilead Sciences Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Novartis AG

        • 11.6.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Novartis AG Self-administered Drugs Product Profiles, Application and Specification

        • 11.6.3 Novartis AG Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Self-administered Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Self-administered Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Self-administered Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Self-administered Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Self-administered Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Injectable Drugs (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Inhaled Drugs (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Transdermal Drugs (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Diabetes (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Osteoporosis (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Pain Management (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Hormone Replacement (2017-2028)

    • Figure Global Self-administered Drugs Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Self-administered Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Self-administered Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Self-administered Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Self-administered Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Self-administered Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Self-administered Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Self-administered Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Self-administered Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Self-administered Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Self-administered Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Self-administered Drugs Market Share, by Manufacturer in 2022

    • Table Global Self-administered Drugs Sales Volume, by Type (2017-2028)

    • Table Global Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Self-administered Drugs Sales Value, by Type (2017-2028)

    • Table Global Self-administered Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Self-administered Drugs Price Trend, by Type (2017-2028)

    • Table China Self-administered Drugs Sales Volume, by Type (2017-2028)

    • Table China Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Self-administered Drugs Sales Value, by Type (2017-2028)

    • Table China Self-administered Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Self-administered Drugs Price Trend, by Type (2017-2028)

    • Table Global Self-administered Drugs Sales Volume, by Application (2017-2028)

    • Table Global Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Self-administered Drugs Sales Value, by Application (2017-2028)

    • Table Global Self-administered Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Self-administered Drugs Sales Value Share, by Application (2017-2028)

    • Table China Self-administered Drugs Sales Volume, by Application (2017-2028)

    • Table China Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Self-administered Drugs Sales Value, by Application (2017-2028)

    • Table China Self-administered Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Self-administered Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Self-administered Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Self-administered Drugs Sales Volume, by Type (2017-2028)

    • Table North America Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Self-administered Drugs Sales Volume, by Application (2017-2028)

    • Table North America Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Self-administered Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Self-administered Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Self-administered Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Self-administered Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Self-administered Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Self-administered Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Self-administered Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Self-administered Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Self-administered Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Self-administered Drugs Sales Value and Growth Rate (2017-2028)

    • Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company Product Profiles, Application and Specification

    • Table Eli Lilly and Company Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Antares Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Antares Pharma Product Profiles, Application and Specification

    • Table Antares Pharma Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gilead Sciences Product Profiles, Application and Specification

    • Table Gilead Sciences Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Self-administered Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.